tradingkey.logo

tradingkey.logo
怜玢


Takeda Pharmaceutical Co Ltd

TAK
りォッチリストに远加
18.260USD
+0.150+0.83%
終倀 09-11 16:00ET
57.74B時䟡総額
47.63盎近12ヶ月PER
時間倖取匕 19:00 (ET)18.260USD-0.015-0.08%

詳现情報 Takeda Pharmaceutical Co Ltd 䌁業名

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.

Takeda Pharmaceutical Co Ltd プロフィヌル


䌁業コヌドTAK
䌚瀟名Takeda Pharmaceutical Co Ltd
䞊堎日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)
埓業員数47455
蚌刞皮類Depository Receipt
決算期末Jun 21
本瀟所圚地4F
郜垂CHUO-KU
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Japan
郵䟿番号103-8668
電話番号81332782111
りェブサむトhttps://www.takeda.com/
䌁業コヌドTAK
䞊堎日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)

Takeda Pharmaceutical Co Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
15.86K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
8.97K
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
7.60K
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
7.60K
--
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
7.60K
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
Mr. Tokumasa Takeda
Mr. Tokumasa Takeda
Global Finance Chief Accounting Officer & Corporate Controller
Global Finance Chief Accounting Officer & Corporate Controller
--
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
15.86K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
8.97K
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
7.60K
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
7.60K
--
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
7.60K
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--

よくある質問

Takeda Pharmaceutical Co Ltdの䞊䜍5名の株䞻は誰ですか


Takeda Pharmaceutical Co Ltdの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Steven H. (Steve) Gillis, Ph.D.

Takeda Pharmaceutical Co LtdTAKの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Takeda Pharmaceutical Co Ltdの株匏を保有しおいる機関は637瀟あり、保有株匏の総垂堎䟡倀は玄85.31Mで、党䜓の2.70%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-8142483.00増加しおいたす。

Takeda Pharmaceutical Co Ltdの最倧の収益源は䜕ですか


2026Q1においお、Gastrointestinal diseases郚門がTakeda Pharmaceutical Co Ltdにずっお最倧の収益を生み出しおおり、その金額は386.10Bで、党収益の31.65%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。